Related / Contacts
Related / News
Press Releases • Jan 29, 2013 13:35 GMT
Press Releases • Jan 31, 2013 08:00 GMT
Exclusive Interview with Nathan Ihle, Executive Director, Process Chemistry & Analytical Biochemistry, Seattle Genetics, USA
Press Releases • Feb 05, 2013 08:09 GMT
Biosimilars are big business. The global biologics market reached $125 billion in 2011, and is predicted to top $150 billion by the end of 2016. Of this, roughly $60 billion will be in off-patent sales.
Europe's Leading Meeting for Bioprocessing Announces Biosimilars, Antibody Drug Conjugates and New Processing Technologies as Key Themes for 2013
Press Releases • Oct 03, 2012 09:00 BST
The pursuit of Biosimilars, Antibody-Drug Conjugates and New Processing Technologies will set the trend for biomanufacturing in 2013; so says research from the industry's leading conference and exhibition, BioProcess International Europe.
Press Releases • Feb 11, 2013 15:44 GMT
Market demands to reduce manufacturing costs require better Cell culture processes
News • Jan 29, 2013 15:48 GMT
Sanofi (SAN) Chief Executive Officer Chris Viehbacher says investors are still underestimating the French company’s pipeline of experimental drugs.
News • Jan 31, 2013 08:00 GMT
Sartorius said today it finished last year with a 20% jump in profits, helped by growing U.S. revenue as well as growth in its bioprocessing, industrial weighing, and lab products and services units.
News • Feb 04, 2013 17:23 GMT
ZURICH, Jan 24 (Reuters) - Swiss specialty chemicals and life sciences group Lonza reported a better than expected rise in profits on Thursday but dampened expectations of another big jump this year, taking the edge off a two-month rally in the share price.
Pfizer Will Evaluate Whether to Divide Drug Units, CEO Read Says Drew Armstrong - ©2013 Bloomberg News
News • Feb 05, 2013 09:00 GMT
Jan. 30 (Bloomberg) -- Pfizer Inc., the world’s largest drugmaker, may consider dividing its branded medicines and generic products units into separate businesses, Chief Executive Officer Ian Read said.